Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year.
Wells Fargo Upgrades Comcast to Equal-Weight, Raises Price Target to $38
Wells Fargo analyst Steven Cahall upgrades Comcast (NASDAQ:CMCSA) from Underweight to Equal-Weight and raises the price target from $30 to $38.
